SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-22-002078
Filing Date
2022-12-02
Accepted
2022-12-02 08:13:51
Documents
13
Period of Report
2022-12-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e4271_8-k.htm   iXBRL 8-K 27414
2 EXHIBIT 99.1 e4271_ex99-1.htm EX-99.1 20980
  Complete submission text file 0001731122-22-002078.txt   227927

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE avxl-20221201.xsd EX-101.SCH 3221
4 XBRL LABEL FILE avxl-20221201_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE avxl-20221201_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT e4271_8-k_htm.xml XML 3603
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 221440300
SIC: 2836 Biological Products, (No Diagnostic Substances)